In the United States, certain minority groups have been shown to have inferior cancer outcomes compared with the white majority population. However, to the authors' knowledge, the majority of research has not separated ethnicity from immigration status. The objective of the current study was to determine the impact of ethnicity, independent of immigration status, on cancer outcomes in Chinese and South Asian populations in Ontario, Canada. METHODS: The authors conducted a population-based retrospective cohort study using administrative databases in Ontario, Canada. Incident cancer cases were captured in Canadian-born Chinese and South Asian individuals, Chinese and South Asian immigrants, and the general Ontario reference population (non-Chinese/non-South Asian and non-immigrant) between 2000 and 2012. Subjects were followed until death (all-cause and cancer-specific), and Cox proportional hazard models were used to estimate the impact of Chinese and South Asian ethnicity on cancer outcomes after adjusting for explanatory variables. RESULTS: A total of 423,678 cancer cases were identified; at total of 6631 cases were identified in Canadian-born Chinese individuals and 2752 cases in Canadian-born South Asian individuals. After adjustment, the rate of all-cause mortality was lower for 
INTRODUCTION
Cancer represents a significant burden of disease in Canada; approximately 40% of Canadians will be diagnosed with a malignancy in their lifetime, 1 and 25% of individuals living in Ontario, Canada, are expected to die of cancer in their lifetime. 2 Canada is a very heterogeneous and multicultural nation with a diverse ethnic and immigrant population, and nearly 1 in 5 Canadians identify as a visible minority group, 3 defined as "persons, other than Aboriginal peoples, who are non-Caucasian in race or non-white in color." 4 Chinese and South Asian (Indian, Pakistani, Bangladeshi, and Sri Lankan) individuals represent the 2 largest visible minority groups in Canada, comprising 21% and 25%, respectively, of Canada's visible minority population. 3 Canada's health care system is a publicly funded system that aims to provide universal health care insurance for all medically necessary services to all Canadian residents, including citizens, permanent residents, and landed immigrants. 5 The publicly funded cancer system clearly needs to meet the unique needs and requirements of the diverse, multicultural population, including vulnerable populations. This poses a significant challenge to the Canadian health care system because traditionally newcomer and visible minority populations are found in a lower socioeconomic status in their adoptive country and have lower health literacy and less access to health care, all of which have been shown to adversely affect cancer outcomes in the United States. [6] [7] [8] Considering the cancer burden in the Ontario population, cancer outcomes in these minority populations are an important aspect to consider when examining the province's single-payer cancer system and ensuring equity, a stated goal of Ontario's cancer system. 9 Significant differences exist between Canada and the United States with regard to the demographic composition of immigrants and visible minorities. In contrast to Canada, the largest minority population in the United States is African American. 10 Furthermore, the immigrant experience differs between the 2 countries because immigrants to the United States are less likely to achieve higher levels of education or earn higher wages compared with Canadian immigrants. 11 Moreover, in contrast to the United States, where illegal immigration is not infrequent, 12 Canadian immigration is overwhelmingly legal. There also are considerable variations in the modes of cancer care delivery between the United States and the singlepayer, publically funded system in Canada. In the United States, African American individuals have been shown to bear a disproportionate burden of cancer death. [13] [14] [15] [16] Disparities in cancer follow-up, 17 treatment regimens, 14, 18, 19 socioeconomic status, health insurance, and racial bias 7, 8, 14, 20, 21 are believed to underlie these inequitable cancer outcomes. However, racial disparities in the United States are not limited to African Americans, as Asian American individuals (Chinese, Japanese, Korean, Filipino, and Vietnamese) have been shown to have lower cancer screening rates [22] [23] [24] and higher cancer mortality compared with the general population for certain malignancies such as stomach, liver, and cervical cancer. 25, 26 In Canada, universal health care and the differing immigrant experience may address some of these disparities in access to care for immigrant and visible minority populations compared with the United States. However, understanding the Canadian experience with ethnicity, immigration status, and cancer survival is an important first step before being able to understand the differing effects of the 2 health care systems, and this may be relevant to other countries with universal health care systems.
Although immigration might intuitively be thought of as a negative predictor of health, the "healthy immigrant effect," in which recent immigrants to a foreign country carry improved health outcomes compared with their adoptive population, has previously been documented. [27] [28] [29] [30] [31] Possible explanations for this effect include a positive selection bias whereby healthier individuals of a population are more likely to immigrate than their less healthy counterparts 32, 33 ; health screening of immigrants before acceptance into a country 27 ; and the relatively healthier habits of immigrants such as lower smoking, alcohol, and obesity rates. 34 Although the healthy immigrant effect generally is believed to affect disease incidence, to the best of our knowledge its impact on disease outcomes once a definitive diagnosis is established is less clearly understood. We previously have shown that recent immigrants to Canada have improved cancer outcomes compared with the general population, but that this survival advantage diminishes over time and mortality increases with each year spent in Canada. 35 These results suggest a prominent healthy immigrant effect; however, they do not explore the association between ethnicity (ie, individuals born in Canada who identify as a visible minority ethnicity) and cancer outcomes, which is less well characterized in the literature. Cultural beliefs, health practices, treatment philosophy, social and community supports, and biology can differ between a Canadianborn minority population and an immigrant population, and these factors may have important implications for cancer outcomes. To the best of our knowledge, it is unknown whether ethnicity and immigration status are independently associated with altered cancer outcomes. The objective of the current study was to examine the relationship between ethnicity and immigration and cancer outcomes in the Ontario Cancer System. To this end, we investigated cancer outcomes in Chinese and South Asian immigrant populations and their counterpart Canadianborn populations using a population-based administrative health care database.
MATERIALS AND METHODS

Population and Data Sources
We conducted a population-based retrospective cohort study using anonymized linkable administrative databases housed at the Institute for Clinical Evaluative Sciences in Toronto, Ontario, Canada. These data sets were linked using unique encoded identifiers and analyzed at the Institute for Clinical Evaluative Sciences. The study population was comprised of all incident cases of lung, colorectal, prostate, breast, head and neck, and hematologic malignancies in Ontario diagnosed between January 1, 2000, and December 31, 2012, in patients aged 18 years and with a valid Ontario Health Insurance Plan number from the Ontario Cancer Registry during the study time frame. The end of the study follow-up period was March 31, 2013 . Patients with in situ or previous malignancies were excluded from the current study. Patient cases were ascertained from the Ontario Cancer Registry, which is known to capture approximately 95% of the incident cases in the province. 36, 37 The study cohort was subdivided by ethnicity into Chinese and South Asian (Indian, Pakistani, Bangladeshi, and Sri Lankan) populations and, within these ethnicity categories, were classified further by immigration status (recent immigrant, non-recent immigrant, and Canadianborn). Chinese and South Asian ethnicities were identified using a previously validated algorithm. 38 The algorithm used surnames to identify patients with Chinese or South Asian ethnicity. Immigration status was defined by the time from immigration to Canada to cancer diagnosis, in which a recent immigrant was someone with a status between 0 to 10 years, non-recent immigrant status was between 11 to 25 years, and Canadian-born comprised individuals who were non-immigrants (or who had immigrated >25 years before their cancer diagnosis). Immigration status was identified using the Ontario portion of the Immigration, Refugees and Citizenship Canada's permanent resident database, which identifies all legal immigrants who have arrived in Ontario from 1985 onward. Demographic and disease-specific characteristics were collected and described for each group.
Outcomes and Data Analysis
The primary outcome of the current study was time to death, which was measured from the time of cancer diagnosis (combined for all cancer types) and up to March 31, 2013 . Cancer-specific mortality was available for all patients diagnosed with cancer before January 1, 2011, with a follow-up period to December 31, 2011. Cox proportional hazards models were constructed to evaluate the effect of ethnicity and immigration status on the hazard ratio (HR) for all-cause death, whereas cause-specific hazard models were used to model the HR for cancer-specific mortality, treating non-cancer mortality as a competing risk. 39 We examined the effect of immigration separately among Chinese and South Asian populations. For example, Canadian-born Chinese individuals, Chinese recent immigrants, and Chinese non-recent immigrants were compared with the general reference population. Similarly, Canadian-born South Asian individuals, South Asian recent immigrants, and South Asian non-recent immigrants were compared with the general reference population. The general reference population consisted of non-Chinese/non-South Asian and non-immigrant patients with a new cancer diagnosis, with the exception of those who had immigrated to Canada before 1985 and did not have a corresponding record in the Immigration, Refugees and Citizenship Canada file and therefore were included in the reference population. We chose to exclude non-Chinese/non-South Asian immigrants from the reference population to isolate ethnicity and immigration status for our comparisons. To control for potential confounding effects, subsequent multivariable analysis was performed to adjust for age, sex, type of cancer, stage of disease at diagnosis, metastatic status, year of cancer diagnosis, rural/urban status, quintile of neighborhood income, and comorbidities. Stage data were available for patients with colorectal, lung, breast, and prostate cancer from 2007 onward, and partial stage data were available for patients with head and neck cancer from 2008 onward. When stage data were not available, we categorized solid tumors as metastatic or non-metastatic based on International Classification of Diseases, 10th Revision (ICD-10) codes and hematologic cancers as curative or noncurative. 35 Preexisting comorbidities were categorized using the Johns Hopkins weighted Aggregated Diagnosis Groups (ADGs) comorbidity score. 40 Quintile of neighborhood income was identified by linkage of the patient postal code from the Registered Person Database to Statistics Canada 2006 census data regarding average household income by postal code.
Secondary analysis was performed to investigate mortality stratified by cancer type. We matched Canadian-born Chinese and South Asian patients with the general population for the secondary analysis to isolate the impact of ethnicity on cancer outcomes given the heterogeneous nature of the study population. Matching occurred in a 1:1 ratio for age (61 year), diagnosis (cancer type), year of cancer diagnosis, urban or rural status, stage of disease at the time of diagnosis, and sex when appropriate. We adjusted for comorbidity and socioeconomic status in subsequent regression analyses, but did not match for these variables due to less consistently available data. Matching was done without replacement.
Statistical Analysis
All analyses were performed with SAS statistical software (version 9.1.3; SAS Institute Inc, Cary, North Carolina), and statistical significance was determined using 95% confidence intervals (95% CIs) to estimate the effect sizes. No adjustments to the CIs for multiple comparisons were made. The proportional hazards assumption was assessed for all Cox models using a log(-log(survival)) plot and a model with time-dependent covariate (time and log(-time)), and no violation of the assumption was found. The study was approved by the Sunnybrook Health Sciences Centre institutional review board. 
RESULTS
Demographics
Main Analyses
Univariate analysis demonstrated that the rate of all-cause and cancer-specific mortality was lower in Canadian-born Chinese and Canadian-born South Asian populations compared with the general population (Tables 2 and 3) . On multivariable analysis, ethnicity retained its protective effect; the HR for all-cause mortality was lower in Canadian-born Chinese (HR, 0.829; 95% CI, 0.795-0.865) and Canadian-born South Asian (HR, 0.856; 95% CI, 0.797-0.919) populations compared with the general population. A similar effect was found for cancer-specific (Tables 2 and 3) .
To isolate the impact of ethnicity on outcomes, secondary univariate analyses based on Canadian-born Chinese and Canadian-born South Asian populations matched to the general population demonstrated that Canadian-born Chinese individuals had lower rates of all-cause and cancer-specific mortality for all cancer subtypes with the exception of cancer-specific mortality for hematologic malignancies (Tables 4 and 5 ). (Tables 4 and 5) .
DISCUSSION
In the current population-based retrospective cohort study, we found that after removing the welldocumented protective effect of immigration, [27] [28] [29] [30] [31] Chinese and South Asian ethnicities are associated with improved cancer outcomes. In particular, Canadian-born Chinese and South Asian individuals have lower all-cause and cancer-specific mortality compared with the general Ontario population. A survival advantage also was found in Chinese immigrants (recent and non-recent), with a trend toward survival in South Asian immigrants (recent and non-recent). Although improved cancer outcomes have been shown in Asian (Chinese, Japanese, Filipino, Korean, and Vietnamese) populations in North America, 8, [41] [42] [43] [44] [45] [46] to the best of our knowledge these studies have not separated the impact of immigration status from ethnicity. Thus, the results of the current study are important in that they begin to disentangle the relative effects of immigration and ethnicity on cancer outcomes, highlighting a survival advantage associated with Chinese and South Asian ethnicities in Ontario, Canada, that was independent of immigration.
The literature regarding the effect of Asian ethnicity on cancer outcomes remains controversial. Some studies have shown a protective effect of Asian ethnicity, 8, [41] [42] [43] [44] [45] [46] whereas some have not supported this finding [47] [48] [49] and other research has suggested variable outcomes, with Korean American individuals demonstrating worse and Japanese American individuals demonstrating improved cancer survival compared with white individuals. 50 Other studies have shown overall better cancer outcomes in Asian American individuals but with worse outcomes in individual cancers such as breast and lung. 44, 51 A Canadian study demonstrated that female Chinese Canadian individuals have lower breast and cervical cancer mortality whereas South Asian Canadian individuals have lower colorectal cancer mortality compared with the general British Columbia population; however, immigrant and Canadian-born Chinese and South Asian individuals were grouped together, making it difficult to determine whether this is predominantly an effect of immigration or ethnicity. 43 The results of the current study found a persistent survival advantage among Chinese patients with cancer in Canada, regardless of whether they were immigrants or Canadian-born, arguing for a potential biologic advantage, cultural advantage (eg, increased family/caregiver support), or even perhaps an altered treatment philosophy due to cultural differences (eg, increased aggressive treatment with antineoplastic agents). It is interesting to note that Chinese, Japanese, and Filipino American women previously have been shown to be more likely than non-Asian American women to pursue more aggressive cancer treatment for early-stage breast cancer. [52] [53] [54] Thus, the cultural beliefs of and approaches to treatment among the Chinese ethnic population may play an important role in improved cancer survival in Canadian-born and immigrant Chinese individuals. However, further work needs to be done to better understand the complex relationship between ethnicity, immigration status, and cancer outcomes. An important consideration is the possibility of altered or significant differences in tumor biology in Chinese versus non-Chinese patients with cancer. Our secondary analysis demonstrated the trend toward a survival advantage for Chinese ethnicity across all cancers, but was statistically significant for lung and prostate cancers. This secondary analysis is hypothesis-generating in that a closer examination of lung and prostate cancer in Chinese patients may reveal significant differences in tumor biology compared with Western patients. This is in keeping with previous research demonstrating Asian ethnicity to be a favorable prognostic factor for survival in patients with non-small cell lung cancer that is independent of smoking status, and differences in tumor biology and epidermal growth factor receptor status were postulated to underlie this effect. 45 Although the results of the current study may suggest an underlying difference in tumor biology between Chinese and non-Chinese individuals for certain malignancies, more research in this area clearly is needed.
Although one may intuitively conclude that immigrants and minority ethnic groups might have worse cancer outcomes due to the associated hardships of immigration, assimilation barriers, or lower socioeconomic status often observed in minority populations, the results of the current study indicate that Chinese immigrants have better cancer outcomes compared with the general Ontario population. The "healthy immigrant effect" has been well documented, in which despite the difficulties of immigration, the general health of new immigrants is improved over that of their adoptive population. [27] [28] [29] [30] [31] Our group recently has shown the healthy immigrant effect on cancer outcomes in a general immigrant population in Ontario, among whom with each year after immigration their cancer outcome appeared to regress to that of the Canadian population. 35 The results of this study argue against the usually temporary healthy immigrant effect, because non-recent immigrants with up to 25 years between immigration and their cancer diagnosis were found to still retain a survival advantage. This is in contrast to the literature, in which with time immigrants usually undergo a process of acculturation, develop poorer health habits, and face pressures associated with lower socioeconomic status, all of which contribute to a decline in health with increasing years since immigration. 27, 29, 30 Although there was an increase in the HR noted among non-recent compared with recent Chinese immigrants suggesting a degree of acculturation that negatively impacted cancer survival, non-recent Chinese immigrants still retained a significantly lower HR compared with the general reference population. This finding is suggestive of a more permanent etiology for improved cancer outcomes in Chinese ethnic groups whether biological, cultural, or behavioral in nature, and future research in this area is needed.
Similar to Canadian-born Chinese individuals, Canadian-born South Asian individuals also demonstrated a lower rate of cancer mortality compared with the general population, indicating that South Asian ethnicity is associated with improved cancer outcomes. Although there was a trend toward improved survival in the South Asian immigrant population, this did not reach statistical significance. Moreover, the survival pattern differed between South Asian and Chinese immigrants, such that the HR was lower for non-recent South Asian immigrants compared with recent South Asian immigrants, suggesting that their cancer survival improved with time since immigration. However, it is difficult to interpret this pattern because the South Asian population had a much smaller sample size than the Chinese population, and this differing pattern of mortality may be a result of the smaller sample size. It is interesting to note that the multivariable adjustment had a larger impact on cancer survival in the South Asian population compared with the Chinese population. However, because the multivariable models were the same between the Chinese and South Asian populations, this also is likely related to the smaller South Asian sample size. More research is warranted to further explore the effect of immigration on cancer survival in a South Asian population to determine whether a persistent cancer survival advantage exists, as was noted among Chinese immigrants.
In contrast to the current study results, ethnic differences in cancer survival in the United States exist whereby non-white minority populations demonstrate higher rates of cancer mortality compared with the majority white population. [13] [14] [15] [16] 25, 48, 49 Much of the literature in the United States has focused on the ethnic disparity in cancer outcomes between African American and white populations, [13] [14] [15] [16] and this ethnic disparity in cancer survival is increasing over time. 16 However, poorer cancer outcomes in the United States are not only found in African American individuals because Asian ethnicity and immigrant status have been associated with worse cancer outcomes in certain cancer types. Asian and Pacific Islanders in the United States have higher stomach, liver, and cervical cancer mortality rates than white individuals, 25, 26, 49 and South Asian individuals have a lower overall cancer survival compared with the US white population. 48 Moreover, Chinese, Japanese, and Filipino immigrants have a lower life expectancy and higher cancer mortality compared with a US non-immigrant population. 25 Health care use has been shown to be lower among Asian American individuals as lower breast and cervical cancer screening rates have been demonstrated in this population compared with white individuals. [22] [23] [24] It is interesting to note that a lack of health care insurance in the United States disproportionately impacts Asian American individuals, as approximately 48% of uninsured Asian Americans did not undergo cervical cancer screening compared with 7% of uninsured white individuals. 22 Access to private health care insurance 55, 56 and regular health care 24, 57 have been shown consistently to be among the strongest predictors of decreased cancer screening in Asian American populations. The disparity between the US results and the findings of the current study may suggest that easier access to care in a Canadian single-payer system contributes to improved cancer outcomes in Canadian-born and immigrant Chinese and South Asian individuals. However, because the purpose of the current study was to describe the Canadian experience with Chinese/South Asian ethnicity, immigration status, and cancer outcomes, it is difficult to draw any conclusions regarding the impact of differing health care systems on the results of the current study. The relationship between modes of cancer care delivery between a private and public health care system and outcomes among vulnerable and minority populations needs to be explored further. Limitations of the current study include a lack of information regarding immigration status before 1985. As a result, the general reference population may have included immigrants (non-Asian) who came to Canada before 1985 and who were not classified as immigrants. However, because data were collected regarding incident cancer cases from 2000 onward and immigration status was limited up to 25 years before diagnosis, there is a relatively small window of immigration between 1975 and 1984 during which a patient could be non-classified. Therefore, the non-classified immigrant patients are likely to be a very small percentage of the 406,735 patients in the reference population. Moreover, this effect likely would bias the results of the current study toward the null hypothesis because Canadian immigrants have been shown to have improved cancer survival compared with the non-immigrant Canadian population. 35 A second limitation of the current study is the use of a name algorithm to detect Chinese and South Asian ethnicities, which excluded patients with names shared by 2 ethnicities and as a result, its sensitivity is lower than its specificity. This may result in certain subgroups with common last names being excluded from the current study. Third, despite our best attempts to control for confounding factors, we realize that there are many factors that may differ between ethnic and immigrant populations that are not identifiable in large administrative databases, such as differing levels of community/social support and degree of acculturation. Fourth, we did not include cancer treatment as a covariate in the multivariable analysis because the initial research aim of the current study was to determine the effect of ethnicity and immigration on cancer outcomes as a predictor of cancer outcomes present at the index date (at the baseline time of cancer diagnosis). However, exploring the impact of treatment on the improved survival associated with Chinese and South Asian ethnicity, and how ethnicity might impact cancer treatment and the quality of cancer care, is the subject of future work. Fifth, although including urban/rural status as a covariate in the multivariable analysis is important due to the large geographical size of Ontario, the small percentage of rural patients among the Chinese and South Asian immigrant groups may lead to model instabilities. Last, the retrospective nature of and use of an administrative database in the current study prevent us from being able to identify more specific family and cultural issues (such as attitude toward treatments or decision-making processes) that may underpin the results of the current study.
The results of the current study demonstrate that Chinese and South Asian ethnic groups have lower cancer mortality rates compared with the general non-immigrant Ontario population. These findings indicate that after removing the well-documented protective effect of immigration, Chinese and South Asian ethnicities are associated with a cancer survival advantage in Ontario. 
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